H. Lundbeck A/S- (NASDAQ:HLUYY) has earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Zacks has also assigned H. Lundbeck A/S- an industry rank of 208 out of 265 based on the ratings given to its competitors.

Several brokerages have weighed in on HLUYY. Zacks Investment Research cut H. Lundbeck A/S- from a “buy” rating to a “hold” rating in a report on Friday, July 29th. Deutsche Bank AG cut H. Lundbeck A/S- from a “buy” rating to a “hold” rating in a research note on Wednesday, August 31st.

H. Lundbeck A/S- (NASDAQ:HLUYY) opened at 32.195 on Friday. H. Lundbeck A/S- has a 12 month low of $28.52 and a 12 month high of $42.17. The stock’s market capitalization is $6.35 billion. The firm has a 50-day moving average price of $36.19 and a 200 day moving average price of $37.31.

About H. Lundbeck A/S-

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia.

5 Day Chart for NASDAQ:HLUYY

Get a free copy of the Zacks research report on H. Lundbeck A/S- (HLUYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for H. Lundbeck A/S- Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S- and related companies with MarketBeat.com's FREE daily email newsletter.